Mario Cazzola | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mario Cazzola is active.

Explore More

Publication

Featured researches published by Mario Cazzola.

Blood | 1990

Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects

Mario Cazzola; Gaetano Bergamaschi; Laura Dezza; Paolo Arosio

Blood | 2004

Quality of Life and Economic Impact of Red Blood Cell (RBC) Transfusions on Patients with Myelodysplastic Syndromes (MDS).

S. Brechignac; E. Hellström-Lindberg; David Bowen; T. M. DeWitte; Mario Cazzola; Pierre Fenaux

Blood | 2006

Immunophenotypic, Cytogenetic and Functional Characterization of Circulating Endothelial Cells in Myelodysplastic Syndromes.

Matteo G. Della Porta; Luca Malcovati; Gian Matteo Rigolin; Vittorio Rosti; Erica Travaglino; Emanuela Boveri; Anna Gallì; Sabrina Boggi; Rosangela Invernizzi; Mario Cazzola

Archive | 2014

myelofibrosis in primary MPL , or CALR , JAK2 Clinical effect of driver mutations of

Mario Cazzola; Vittorio Rosti; Francisco Cervantes; Giovanni Barosi; Chiara Cavalloni; Carmela Mannarelli; Chiara Milanesi; Emanuela Boveri; Dolors Colomer; Lisa Pieri; Giada Rotunno; Elisa Rumi; Daniela Pietra; Cristiana Pascutto; Paola Guglielmelli; Alejandra Martínez-Trillos

Archive | 2014

treated with ruxolitinib in the COMFORT-II study Impact of mutational status on outcomes in myelofibrosis patients

Enrico Tagliafico; Alessandro M. Vannucchi; Matthew Squires; Mario Cazzola; Rossella Manfredini; Claire N. Harrison; Elena Tenedini; Lisa Pieri; Chiara Paoli; Carmela Mannarelli; Flavia Biamonte; Giada Rotunno; Valentina Artusi; Lucia Artuso

Archive | 2013

myeloproliferative disorders Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative

Maurizio Ferrari; Heinz Gisslinger; Robert Kralovics; Laura Cremonesi; Radek C. Skoda; Mario Cazzola; Daniela Pietra; Sai Li; Angela Brisci; Francesco Passamonti; Elisa Rumi; Alexandre Theocharides

Archive | 2013

exon 12 mutations JAK2 associated with Molecular and clinical features of the myeloproliferative neoplasm

Daniela Pietra; Cristiana Pascutto; Torsten Haferlach; Mario Cazzola; Alessandro M. Vannucchi; Eric Lippert; Heinz Gisslinger; Elisa Rumi; Thomas Lehmann; Jean-Jacques Kiladjian; Mary Frances McMullin; Marco Ruggeri; Carles Besses; Francesco Passamonti; Chiara Elena; Susanne Schnittger; Radek C. Skoda; Anthony R. Green

Archive | 2013

Phenotypes and Specific Mutations in the Iron-Responsive Element of Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between

Giovanni Barosi; Paolo Emilio Bianchi; Gaetano Cairo; Paolo Arosio; Mario Cazzola; Gaetano Bergamaschi; Laura Tonon; Eloisa Arbustini; Maurizia Grasso; Elena Vercesi

Archive | 2013

myeloid and lymphoid neoplasms in SF3B1 Biologic and clinical significance of somatic mutations of

Mario Cazzola; Marianna Rossi; Luca Malcovati

Archive | 2013

syndromes characterize early erythroid precursors in low-risk myelodysplastic Aberrant mitochondrial iron distribution and maturation arrest

E. Hellström-Lindberg; Erica Travaglino; Jan Samuelsson; Robert Hast; Lars J Nilsson; Mario Cazzola; Rosangela Invernizzi; Alf Grandien; Boris Zhivotovsky; Bengt Fadeel

Explore More